Arkolith/Insider Trading/KLRS/Form 4

Samsara Opportunity Fund, L.P.

10% OwnerKalaris Therapeutics, Inc. (KLRS) · full profile →Form 4 · filed Feb 17, 2026
Net Buying
Open-Market Buys
$5.0M
Open-Market Sells
$0
Net Open-Market Flow
$5.0M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 18, 2025Buy(P)480K$10.42$5.0M2.0M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001231919-26-000166) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML